Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02724605
Other study ID # IRB0000871236
Secondary ID
Status Completed
Phase Phase 2
First received March 20, 2016
Last updated January 4, 2018
Start date January 2016
Est. completion date August 2017

Study information

Verified date January 2018
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to detect if the storage duration of red blood cells has impact on some biochemical parameters after intra operative transfusion in pediatric trauma patient


Description:

- A pretransfusion draw of a few drops of patient venous blood, send for analysis by i-STAT Portable Clinical Analyser. Samples are processed immediately and provide laboratory quality results in 2 minutes using the CHEM 8+ i-STAT cartridge for measurement of:

1. Potassium (K)

2. Ionized Calcium (iCa)

3. Glucose (Glu)

4. Urea Nitrogen (BUN)/Urea

5. Hemoglobin (Hb) and Hematocrit (Hct).

- Concurrently, a few drops of blood will be taken from the unit to be transfused will be analysed by i-STAT Portable Clinical Analyser for measurement of previous biochemical parameters.

- The details of the unit, such as draw date, volume of transfusion, and date of transfusion, will be recorded. The RBC unit will be delivered to the operative room from the blood bank in an insulated box.

- The transfusion is then given as clinically indicated at a rate of 50 to 150 mL/h based on the clinician's orders, the patient's weight, and the patient's clinical situation.

- Volumes will be transfused to children according to the following top-up transfusion equation: desired Hemoglobin (Hb) (g/dl) - actual Hemoglobin (Hb) (g/dl) x weight (kg) x 3. (usually 10-20 ml/kg).

- A second patient blood sample will be drawn one hour after the transfusion and will be analyzed by i-STAT Portable Clinical Analyser.

- Patient information will be recorded for age, weight, sex, and primary diagnosis.

- Demographic and clinical variables will be collected, to include type and quantity of all blood products and fluids received and medications administered. All surgical procedures will be documented.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date August 2017
Est. primary completion date June 2017
Accepts healthy volunteers No
Gender All
Age group 2 Years to 10 Years
Eligibility Inclusion Criteria:

.ASA I-II physical status patients.

- Genders Eligible for Study : both .

- Age: 2_10 years

- All non-crush trauma pediatric patients need intraoperative RBC transfusion.

- RBCs transfusion Volume within 10-20ml/kg.

Exclusion Criteria:

- Patients with renal failure (serum creatinine 1.5 mg/dL)

- Hepatic insufficiency.

- Furosemide diuresis.

- Succinylcholine for rapid sequence induction.

- Electrolytes disorders.

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
Red blood cells unit age 14 days or less
30 Patients who will receive units of packed red blood cells stored stored for 14 days or less
Red blood cells unit age more than 14 days
30 patients who will receive units of packed red blood cells stored for more than 14 days

Locations

Country Name City State
Egypt Assiut university faculty of medicine Assiut

Sponsors (2)

Lead Sponsor Collaborator
Abdelrady S Ibrahim, MD Assiut University

Country where clinical trial is conducted

Egypt, 

References & Publications (1)

Qu L, Triulzi DJ. Clinical effects of red blood cell storage. Cancer Control. 2015 Jan;22(1):26-37. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Serum potassium level Mmol/l One hour after red blood cells transfusion
Secondary Serum ionised calcium mg/dl One hour after red blood cells transfusion
Secondary Serum glucose level Mmol/l One hour after red blood cells transfusion
Secondary Blood Urea Nitrogen mg/dL One hour after red blood cells transfusion
Secondary Hemoglobin level g/dl One hour after red blood cells transfusion
See also
  Status Clinical Trial Phase
Completed NCT01502215 - Transfusion Requirements in Surgical Oncologic Patient Phase 3